melanotan 2 for men: Frequently asked questions

Maintenance protocols use 0.01mg/kg twice weekly after reaching desired pigmentation. The tan will fade gradually over 4–6 weeks if you stop entirely, as melanin-containing keratinocytes are shed through normal skin turnover. Maintenance dosing extends the tan indefinitely but doesn't prevent eventual fading if stopped. Some users report that combining maintenance MT-2 with occasional brief UV exposure (10 minutes twice weekly) maintains pigmentation with lower peptide doses.

You'll still tan. Melanogenesis occurs independently of UV exposure because MT-2 directly activates MC1R receptors. However, the tan will be lighter than if you combine peptide use with controlled UV exposure. Some users report a 'base tan' within 7–10 days using MT-2 alone, while others combine low-dose MT-2 (0.01mg/kg) with 10–15 minutes of natural sunlight twice weekly to accelerate visible pigmentation. The peptide doesn't require UV to work, but UV exposure amplifies the effect by triggering the complementary p53-mediated melanin pathway.

Melanogenesis requires UV exposure. Melanotan-2 upregulates tyrosinase (the enzyme converting tyrosine to melanin), but melanin synthesis only occurs when melanocytes are activated by ultraviolet radiation. If you inject melanotan-2 but avoid sun exposure entirely, minimal tanning will occur. For men over 40 whose primary interest is sexual function rather than pigmentation, this is irrelevant. The MC4R-mediated effects on libido and erections occur independently of melanin production.

Stop using the peptide immediately and schedule a dermatology evaluation. MT-2 stimulates all melanocytes indiscriminately, including those in existing moles. Darkening or growth of moles can indicate accelerated activity in atypical melanocytes. A 2009 study in Archives of Dermatology documented three cases of rapid mole changes in MT-2 users, two of which were later diagnosed as melanoma in situ. If you have more than 10 moles or any atypical moles, do not use melanotan-2 without dermatologic clearance.

Seek immediate medical attention. Priapism (erection lasting >4 hours) can cause permanent erectile tissue damage if untreated. This is rare at standard doses (0.025mg/kg) but becomes more likely above 0.03mg/kg. The treatment is typically intracavernosal injection of phenylephrine to reverse the nitric oxide-driven vasodilation. Our experience reviewing case reports suggests this occurs almost exclusively in users who exceed recommended dosing or combine MT-2 with PDE5 inhibitors.

Reduce the dose to 0.25mg and administer it in the evening rather than morning. Nausea correlates with peak plasma concentration, and evening dosing allows you to sleep through the 60–90 minute window when nausea is most likely. Nausea occurs because MC4R activation in the area postrema (the brain's chemoreceptor trigger zone) signals the digestive system to slow gastric emptying. The effect diminishes with repeated exposure as MC4R desensitisation occurs in peripheral tissues while central nervous system receptors remain responsive.

Erections lasting 2–3 hours are within normal range for melanotan-2 at therapeutic doses and do not constitute priapism. True priapism. Defined as an erection persisting beyond four hours without detumescence. Requires immediate medical intervention to prevent ischemic tissue damage. If an erection lasts longer than three hours, apply ice to the perineum and perform light cardiovascular activity (walking, cycling) to redirect blood flow. Priapism has been documented only at doses exceeding 2mg per administration. Standard protocols use 0.25–1mg.

Melanotan-2 and testosterone replacement therapy operate through entirely separate mechanisms and can be used concurrently without interaction. TRT restores androgen receptor signalling; melanotan-2 activates melanocortin receptors. The combination addresses both androgen deficiency and melanocortin pathway dysfunction. Men on TRT who still experience reduced libido or erectile quality often see improvement when melanocortin signalling is restored. Monitor blood pressure more closely when combining the two, as both can mildly elevate systolic pressure.